Mechanisms and clinical significance of multidrug resistance.

C. S. Morrow, K. H. Cowan

Research output: Contribution to journalReview article

92 Citations (Scopus)

Abstract

Tumor cells often become refractory to diverse drugs with different mechanisms of cytotoxic action. This paper reviews the current state of our knowledge of multidrug resistance, the limitations of present concepts to fully explain the diversity of the MDR phenotypes, and the clinical relevance of these studies derived largely from cell culture systems. The authors discuss the use of markers associated with the multi-drug resistance phenotype to identify potentially drug-resistant tumors and outline strategies that might be used to overcome the resistance phenomenon.

Original languageEnglish (US)
Pages (from-to)55-63, 66
JournalOncology (Williston Park, N.Y.)
Volume2
Issue number10
StatePublished - Oct 1 1988

Fingerprint

Multiple Drug Resistance
Phenotype
Pharmaceutical Preparations
Neoplasms
Cell Culture Techniques
Clinical Studies

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Mechanisms and clinical significance of multidrug resistance. / Morrow, C. S.; Cowan, K. H.

In: Oncology (Williston Park, N.Y.), Vol. 2, No. 10, 01.10.1988, p. 55-63, 66.

Research output: Contribution to journalReview article

@article{17be8d9d28c3483591010b744153b72a,
title = "Mechanisms and clinical significance of multidrug resistance.",
abstract = "Tumor cells often become refractory to diverse drugs with different mechanisms of cytotoxic action. This paper reviews the current state of our knowledge of multidrug resistance, the limitations of present concepts to fully explain the diversity of the MDR phenotypes, and the clinical relevance of these studies derived largely from cell culture systems. The authors discuss the use of markers associated with the multi-drug resistance phenotype to identify potentially drug-resistant tumors and outline strategies that might be used to overcome the resistance phenomenon.",
author = "Morrow, {C. S.} and Cowan, {K. H.}",
year = "1988",
month = "10",
day = "1",
language = "English (US)",
volume = "2",
pages = "55--63, 66",
journal = "Oncology",
issn = "0890-9091",
publisher = "UBM Medica Healthcare Publications",
number = "10",

}

TY - JOUR

T1 - Mechanisms and clinical significance of multidrug resistance.

AU - Morrow, C. S.

AU - Cowan, K. H.

PY - 1988/10/1

Y1 - 1988/10/1

N2 - Tumor cells often become refractory to diverse drugs with different mechanisms of cytotoxic action. This paper reviews the current state of our knowledge of multidrug resistance, the limitations of present concepts to fully explain the diversity of the MDR phenotypes, and the clinical relevance of these studies derived largely from cell culture systems. The authors discuss the use of markers associated with the multi-drug resistance phenotype to identify potentially drug-resistant tumors and outline strategies that might be used to overcome the resistance phenomenon.

AB - Tumor cells often become refractory to diverse drugs with different mechanisms of cytotoxic action. This paper reviews the current state of our knowledge of multidrug resistance, the limitations of present concepts to fully explain the diversity of the MDR phenotypes, and the clinical relevance of these studies derived largely from cell culture systems. The authors discuss the use of markers associated with the multi-drug resistance phenotype to identify potentially drug-resistant tumors and outline strategies that might be used to overcome the resistance phenomenon.

UR - http://www.scopus.com/inward/record.url?scp=0024093140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024093140&partnerID=8YFLogxK

M3 - Review article

C2 - 3079288

AN - SCOPUS:0024093140

VL - 2

SP - 55-63, 66

JO - Oncology

JF - Oncology

SN - 0890-9091

IS - 10

ER -